In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other best multibagger stocks to buy according to billionaires. US Trade tariffs have ...

In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock ...

ADMA Biologics ADMA reported lower-than-expected results for the first quarter. Adjusted earnings per share of 14 cents missed the Zacks Consensus Estimate of 16 cents. Revenues of $114.8 million ...

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript ADMA Biologics slips as 10-K delay overshadows earnings beat ADMA Biologics GAAP EPS of $0.46 beats by $0.31, revenue of $117.55M beats ...

Adma Biologics shares have risen 38% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $23.61, more than tripling in the last 12 months.

RAMSEY, N.J. and BOCA RATON, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end ...

ADMA delivered outstanding financial and operational results in the first quarter of 2025, with total reported revenues and Adjusted EBITDA growing by 40% and 81% year-over-year, respectively ...

Shares of ADMA Biologics, Inc. ADMA have gained 48.6% (versus the S&P 500’s 3% decrease) since it was upgraded to a Zacks Rank #2 (Buy) on March 4. Another stock, Intrepid Potash, Inc. IPI ...